Andrea Tan

Stock Analyst at Goldman Sachs

(0.29)
# 4,428
Out of 4,651 analysts
62
Total ratings
47.9%
Success rate
-10.9%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andrea Tan

Tarsus Pharmaceuticals
Feb 5, 2026
Maintained: Hold
Price Target: $51$68
Current: $69.20
Upside: -1.73%
Krystal Biotech
Jan 30, 2026
Reiterated: Buy
Price Target: $193$327
Current: $332.27
Upside: -1.59%
Madrigal Pharmaceuticals
Aug 18, 2025
Reiterated: Buy
Price Target: $567
Current: $507.56
Upside: +11.71%
Iovance Biotherapeutics
Jun 3, 2025
Reiterated: Buy
Price Target: $16$8
Current: $6.98
Upside: n/a
Arrowhead Pharmaceuticals
Mar 10, 2025
Reiterated: Hold
Price Target: $28$26
Current: $86.64
Upside: n/a
Kodiak Sciences
Sep 24, 2024
Reiterated: Sell
Price Target: $2
Current: $41.35
Upside: n/a
Insmed
Aug 9, 2024
Maintained: Buy
Price Target: $102$103
Current: $123.74
Upside: n/a
Sagimet Biosciences
Jun 28, 2024
Downgraded: Hold
Price Target: $23$6
Current: $10.55
Upside: n/a
Jazz Pharmaceuticals
Jun 5, 2024
Initiated Coverage: Buy
Price Target: $169
Current: $244.96
Upside: n/a
Relmada Therapeutics
Jun 5, 2024
Downgraded: Sell
Price Target: $8$2
Current: $4.80
Upside: n/a
Reiterated: Hold
Price Target: n/a
Current: $48.74
Upside: n/a
Maintained: Buy
Price Target: $30$24
Current: $11.38
Upside: n/a
Maintained: Sell
Price Target: $4
Current: $2.57
Upside: n/a
Maintained: Hold
Price Target: $6$4
Current: $23.03
Upside: n/a